AEVI GENOMIC MEDICINE, INC.

AEVI GENOMIC MEDICINE

Pharmaceutical products, namely, treatments for pediatric onset and rare and orphan disorders; biological and chemical preparations for medical and veterinary use; antibodies for medical and veterinary use; proteins, enzymes, and peptides for medical and veterinary use; small molecule drugs for use in treatments for pediatric onset and rare and orphan disorders; reagents for medical use; diagnostic reagents and diagnostic assays for medical use; therapeutic agents for use in treatments for pediatric onset and rare and orphan disorders; immunotherapeutics and immunologics for use in treatments for pediatric onset and rare and orphan disorders; viral, retroviral, and non-viral vectors for use in treatments for pediatric onset and rare and orphan disorders; vaccines; adjuvants; pharmaceutical preparations for the treatment of rare and difficult-to-treat diseases; biological materials, namely, genetically modified autologous tissue implants, intended to produce proteins for therapeutic uses;Reagents for research purposes; assays for research purposes;Medical services, namely, harvesting tissue from a patient, genetically modifying that tissue and then reintroducing it into the same patient for therapeutic purposes; medical services;Medical devices and instruments for genetically modifying tissue;GENOMIC MEDICINE;Medical research; pharmaceutical drug development services; testing, inspection, research, or development of pharmaceutical preparations for gene therapy;

TARGT

Biological materials, namely, genetically modified autologous tissue implants, intended to produce proteins for therapeutic uses;TARGET;Medical services, namely, harvesting tissue from a patient, genetically modifying that tissue and then reintroducing it into the same patient for therapeutic purposes;Medical devices and instruments for genetically modifying tissue;

TARGTEPO

Biological materials, namely, genetically modified autologous tissue implants, intended to produce proteins for therapeutic uses;Medical services, namely, harvesting tissue from a patient, genetically modifying that tissue and then reintroducing it into the same patient for therapeutic purposes;Medical devices and instruments for genetically modifying tissue;